Results

Total Results: 1,034 records

Showing results for "drugs".

181. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
     May 06, 2002 - Evidence that chemopreventive drugs might be able to prevent breast cancer first came to light in the … Although Vitamin A analogs, such as fenretinide, have been investigated as potential drugs for chemoprevention … Discontinuation of study drugs was problematic in all four trials. … Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Although the trade-off between benefits and harms for the present drugs, given current evidence, may

182. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
     April 01, 2016 - medication use (selective serotonin reuptake inhibitors and nonaspirin nonsteroidal anti-inflammatory drugs … In terms of safety, some medications (for example, antiplatelet or anticoagulant drugs) may be considered … Am J Cardiovasc Drugs. 2015;15:113-33. … Increased diver- ticular complications with nonsteriodal anti-inflammatory drugs and other medications … Drugs Aging. 2011;28:345-67. [PMID: 21542658] doi:10.2165/11589340-000000000-00000 63.

183. Chemo and Couns/2nd instal (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
     July 01, 2002 - Evidence that chemopreventive drugs might be able to prevent breast cancer first came to light in the … Although Vitamin A analogs, such as fenretinide, have been investigated as potential drugs for chemoprevention … Discontinuation of study drugs was problematic in all 4 trials. … Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Although the trade-off between benefits and harms for the present drugs, given current evidence, may

184. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - Evidence that chemopreventive drugs might be able to prevent breast cancer first came to light in the … Although Vitamin A analogs, such as fenretinide, have been investigated as potential drugs for chemoprevention … Discontinuation of study drugs was problematic in all four trials. … Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Although the trade-off between benefits and harms for the present drugs, given current evidence, may

185. Archived: Osteoporosis: Screening 2011 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2011
     January 15, 2011 - bisphosphonates for fracture prevention in men at high risk for fractures could help to assess whether these drugs

186. Zr66Ep5Abbqcuqy7Ktdetn (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZR66ep5ABbQCUQy7KTDETn
     July 01, 2014 - Food and Drug Administration has approved 7 anti- viral drugs for treatment of chronic HBV infection: … Evidence on the first-line drugs pegylated inter- feron, entecavir, and tenofovir is limited (1). … fair- to good-quality trials (n � 42 to 638; du- ration, 48 to 96 weeks) compared first-line antiviral drugs … Results for harms were largely consistent when stratified according to indi- vidual drugs (1).

187. Archived: Final Evidence Summary: Lipid Disorders in Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
     July 15, 2007 - adolescents with FH or FCH are the only non-adults for whom trials of drug therapy are available and drugs … of bile-acid binding resins 166 , 176 , 186 , 187 , 209-227 and in eight studies of various other drugs … NR Other drugs and combinations Baker, 1982 26 Probucol 7, 6-21 y 15-21 mo Nausea … Stein, 1989 231 Diet + drug or combined drugs: BABR; BABR + niacin; lovastatin or simvastatin 30, … Statin drugs were associated primarily with elevations in LFTs and CK.

188. Clinical Summary: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/EzrKKtG83uM-jEB3W3vkvm
     January 23, 2019 - Clinical Summary: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum Clinical Summary: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum Population Newborns Recommendation Provide prophylactic ocular topical medication to prevent gonococcal ophthalmia neonatorum. Grade: A Preventi…

189. Understanding Task Force Draft Recommendations - Screening for Atrial Fibrillation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/EmQhQqDP8ErVrxz5e92aW_
     May 17, 2021 - pressure, heart failure, hyperthyroidism (overactive thyroid), or having a prior stroke • Using alcohol, drugs

190. Final Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     September 05, 2019 - defined as three or more vitamins, minerals, or combinations of both without added herbs, hormones, or drugs

191. Archived: Evidence Summary: Dementia in Older Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/dementia-older-adults-screening-2003
     June 03, 2003 - research demonstrates a positive effect of antidepressants on depression, it is not clear that these drugs … to be told of a dementia diagnosis. 118 , 119 The potential harms of treatment apply primarily to drugs … effect rate was from 5% to 20% higher and about 8% higher, respectively, in patients receiving the drugs … Peripheral and Central Nervous System Drugs Advisory Committee Meeting. 17 July 1989. … Other drugs (e.g., Ginkgo biloba , selegiline, vitamin E, estrogen) for Alzheimer's disease.

192. Let's Talk About It: Starting Aspirin to Prevent Heart Disease and Stroke (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/lets-talk-about-it-aspirin-cvd-prevention-guide.pdf
     April 25, 2022 - Some medications, like nonsteroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen and naproxen)

193. Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/eX6ET62JyzurgX2LEoygZK
     April 01, 2020 - Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents 1 www.uspreventiveservicestaskforce.org B Grade Clinician Summary of USPSTF Recommendation Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents April 2020 What do…

194. Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer
     October 07, 2013 - nonsteroidal anti-inflammatory drug use), or concomitant medication use (nonsteroidal anti-inflammatory drugs

195. Archived: Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - nonsteroidal anti-inflammatory drug use), or concomitant medication use (nonsteroidal anti-inflammatory drugs

196. Archived: Evidence Summary: Blood Pressure in Children and Adolescents (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary16/blood-pressure-in-children-and-adolescents-hypertension-screening-october-2013
     February 15, 2013 - Drug Interventions All seven included trials of drug interventions examined different drugs 53-59 … were significant reductions of mean SBP (range 2–10 mm Hg), and mean DBP (range 0.4–8 mm Hg) with some drugs … Consistent Moderate Studies of antihypertensive drugs in children and adolescents generally reported … losartan ( n = 165) Dosages not reported Subjects who reported cough in the cohort receiving active drugs

197. Evidence Summary: Screening for Familial Hypercholesterolemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening
     August 09, 2016 - Eight placebo trials of statin drugs (n = 1071; 6–104 weeks) found low-density lipoprotein cholesterol … For treatment studies (KQs 5–7), interventions using lipid-lowering drugs or lifestyle interventions … All reported clinical and laboratory harms associated with lipid-lowering drugs were included. … Paediatr Drugs . 2015;17(2):159-166. 40. Braamskamp MJ, Kusters DM, Wiegman A, et al. … Paediatr Drugs . 2011;13(4):267-275. 42. Clauss SB, Holmes KW, Hopkins P, et al.

198. Archived: Evidence Summary: Screening for Familial Hypercholesterolemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening-july-2016
     August 09, 2016 - Eight placebo trials of statin drugs (n = 1071; 6–104 weeks) found low-density lipoprotein cholesterol … For treatment studies (KQs 5–7), interventions using lipid-lowering drugs or lifestyle interventions … All reported clinical and laboratory harms associated with lipid-lowering drugs were included. … Paediatr Drugs . 2015;17(2):159-166. 40. Braamskamp MJ, Kusters DM, Wiegman A, et al. … Paediatr Drugs . 2011;13(4):267-275. 42. Clauss SB, Holmes KW, Hopkins P, et al.

199. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Sttb6Qo6TFfWyR7Y8SzfH-
     June 11, 2014 - Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Clinical Summary of USPSTF Recommendation SCREENING FOR HEPATITIS B VIRUS INFECTION IN NONPREGNANT ADOLESCENTS AND ADULTS CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic, nonpregnant ado…

200. Recommendation: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
     March 02, 2020 - most rapid increase in acute HCV incidence has been in young adults aged 20 to 39 years who inject drugs … In the US, recent increases in HCV incidence have predominantly been among young persons who inject drugs … risk factors (eg, persons with HIV, prior recipients of blood transfusions, persons who ever injected drugs